Spotlight on liver macrophages for halting injury and progression in nonalcoholic fatty liver disease
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - October 15, 2022 Category: Drugs & Pharmacology Authors: Tea Lund Laursen Anders Mellemkj ær Holger Jon M øller Henning Gr ønbæk Konstantin Kazankov Source Type: research

Spotlight on liver macrophages for halting liver disease progression and injury
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - October 12, 2022 Category: Drugs & Pharmacology Authors: Amit Khurana Umashanker Navik Prince Allawadhi Poonam Yadav Ralf Weiskirchen Source Type: research

Neuropathic ocular surface pain: Emerging drug targets and therapeutic implications
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - September 20, 2022 Category: Drugs & Pharmacology Authors: Sneh Patel Rhiya Mittal Konstantinos D. Sarantopoulos Anat Galor Source Type: research

Aortic valve stenosis: drivers of disease progression and drug targets for therapeutic opportunities
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - September 7, 2022 Category: Drugs & Pharmacology Authors: Giuseppe Pinto Gabriele Fragasso Source Type: research

Liver X receptor: a potential target in the treatment of atherosclerosis
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - September 6, 2022 Category: Drugs & Pharmacology Authors: Shreya R. Savla Kedar S Prabhavalkar Lokesh K Bhatt Source Type: research

The role of immune response in the pathogenesis of idiopathic pulmonary fibrosis: far beyond the Th1/Th2 imbalance
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - August 30, 2022 Category: Drugs & Pharmacology Authors: Paolo Spagnolo Roberto Tonelli Anna Valeria Samarelli Gioele Castelli Elisabetta Cocconcelli Simone Petrarulo Stefania Cerri Nicol Bernardinello Enrico Clini Marina Saetta Elisabetta Balestro Source Type: research

TROP2 (trophoblast cell-surface antigen 2): a drug target for breast cancer
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - August 19, 2022 Category: Drugs & Pharmacology Authors: Michela Cortesi Michele Zanoni Roberta Maltoni Sara Ravaioli Maria Maddalena Tumedei Francesca Pirini Sara Bravaccini Source Type: research

Neuropathogenesis of HIV and emerging therapeutic targets
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - July 18, 2022 Category: Drugs & Pharmacology Authors: Alina Siddiqui Celestine He Gina Lee Alex Figueroa Alexander Slaughter Jessica Robinson-Papp Source Type: research

Nitric oxide pathway as a plausible therapeutic target in autism spectrum disorders
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - July 18, 2022 Category: Drugs & Pharmacology Authors: Rishab Mehta Anurag Kuhad Ranjana Bhandari Source Type: research

Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - July 7, 2022 Category: Drugs & Pharmacology Authors: Ernestina Marianna De Francesco Francesca Cirillo Veronica Vella Antonino Belfiore Marcello Maggiolini Rosamaria Lappano Source Type: research

Heterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targets
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 8, 2022 Category: Drugs & Pharmacology Authors: Alberto Zambelli Riccardo Sgarra Rita De Sanctis Elisa Agostinetto Armando Santoro Guidalberto Manfioletti Source Type: research

IL-36: a therapeutic target for ulcerative colitis?
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 2, 2022 Category: Drugs & Pharmacology Authors: Yasmina E. Hernandez Santana Naoise Irwin Patrick T. Walsh Source Type: research

Acute myeloid leukemia: therapeutic targeting of stem cells
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 2, 2022 Category: Drugs & Pharmacology Authors: Cindy M. Pabon Hussein A. Abbas Marina Konopleva Source Type: research

Dapagliflozin mitigates ovalbumin-prompted airway inflammatory-oxidative successions and associated bronchospasm in a rat model of allergic asthma
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 2, 2022 Category: Drugs & Pharmacology Authors: Manar Mohammed El Tabaa Aliaa Mohammed Kamel Fattah Mohamed Shaalan Eman Rashad Nageh Ahmed El Mahdy Source Type: research

TAR DNA-binding protein of 43 kDa (TDP-43) and amyotrophic lateral sclerosis (ALS): a promising therapeutic target
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 2, 2022 Category: Drugs & Pharmacology Authors: Yara Al Ojaimi Audrey Dangoumau Hugo Alarcan Rudolf Hergesheimer Patrick Vourc ’h Philippe Corcia D ébora Lanznaster H élène Blasco Source Type: research